Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry-Funded CME To Go Way Of Dinosaurs? ACCME Comments Lumber In

Executive Summary

The pharmaceutical industry continues to retrench how it provides continuing medical education in response to public and congressional pressure, but firms are also marshalling for a fight against an outright ban

Related Content

Social Networking Sites: Small Step For Firms, Giant Leap For Research
CME providers to pay more to be monitored
Physician Payment Disclosure Bill Should Include Other Entities – MedPAC
CME Reforms Under PhRMA Code Increase The Influence Of ACCME
Drug Rep Repasts Are In The Past: PhRMA Code Further Restricts Free Meals
Pfizer CME Restrictions: No Support For Education Firms, Caps Everywhere Else
ACCME Poses Four Conditions For Acceptable Industry-Supported CME
ACCME Poses Four Conditions For Acceptable Industry-Supported CME
Amgen CME Grants Equal 0.4% Of Sales – More Than Pfizer, Less Than Lilly
Pfizer Gets Access To Physicians’ Online Conversations Through Sermo Deal



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts